Anti-ricin antibody therapeutic - Fabentech
Alternative Names: RicimedLatest Information Update: 09 Feb 2026
At a glance
- Originator Fabentech
- Class Antidotes; Antitoxins; Fab fragments; Polyclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Ricin poisoning